Kardia 12L and KAI 12L

by AliveCor  · Based in United States → — The easiest way to acquire an accurate 12-lead ECG.
Cardiology Emergency Medicine Internal Medicine

$2295
Regulatory Status Disclosed

Overview

The Kardia 12L system simplifies 12-lead ECG acquisition with a single-cable design and five electrode placements, making it easier and faster to use than traditional 12-lead ECG machines. The accompanying KAI 12L AI technology, trained on over 1.75 million ECGs, can detect up to 39 cardiac determinations, including acute myocardial infarction (MI) and common ischemias, as well as various arrhythmias and morphology determinations. This system aims to expand access to high-quality 12-lead ECGs across diverse care settings, including primary and urgent care offices, employer clinics, and rural venues.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Handheld, portable 12-lead ECG system
  • Single-cable design with 5 electrode placements
  • AI-powered analysis (KAI 12L) for up to 39 cardiac determinations
  • Detection of acute myocardial infarction (MI) and common ischemias
  • Detection of various arrhythmias and morphology determinations (e.g., Short PR Interval, Atrial Bigeminy, Ventricular Bigeminy, Left Axis Deviation, Right Axis Deviation)
  • KardiaStation app for streamlined ECG acquisition and display
  • KardiaPro web portal for secure patient ECG management and review
  • Bluetooth connectivity to compatible smart devices (iOS and Android)
  • Clinically validated performance comparable to standard 12-lead ECGs
  • Unlimited cloud-based data backup

Use Cases

  • Point-of-care cardiac assessment in various clinical settings
  • Rapid detection of life-threatening cardiac conditions
  • Expanding access to 12-lead ECGs in under-resourced or rural venues
  • Simplifying ECG acquisition for healthcare professionals with infrequent ECG experience
  • Monitoring patients for a wide range of cardiac findings
  • Supporting faster clinical decision-making

What Physicians Need to Know

ECG/EKG Analysis Capability
Kardia 12L is an FDA-cleared, AI-powered, handheld 12-lead resting ECG system that acquires four standard diagnostic-bandwidth leads, derives four, and synthesizes four additional leads for a complete 12-lead recording. The KAI 12L AI technology, trained on over 1.75 million ECGs, can detect 39 cardiac determinations, including 16 arrhythmias and 23 morphologies. It offers two analysis modes: Asymptomatic (optimized for high specificity) and Symptomatic (optimized for high sensitivity).
Arrhythmia Detection Accuracy
The KAI 12L AI can identify major rhythm types including AFib, atrial flutter, 1st degree AV block, and various tachycardias. It also detects Short PR Interval, Atrial Bigeminy, Ventricular Bigeminy, Left Axis Deviation (LAD), and Right Axis Deviation (RAD). The symptomatic mode utilizes lower thresholds (0.7 probability) to maximize sensitivity for AFib detection. The system has identified over 4,000 instances of myocardial infarction and ischemia.
Heart Failure Risk Prediction
Specific heart failure risk prediction is not explicitly detailed as a feature for Kardia 12L or KAI 12L. The focus is on detection of various cardiac conditions and arrhythmias.
Coronary Artery Assessment
KAI 12L can detect serious conditions like acute myocardial infarction (MI) and the most common types of cardiac ischemia.
Cardiac Monitoring Integration
The Kardia 12L system works with the KardiaStation app for recording, displaying, and uploading ECG data. Data can be managed and reviewed securely through the KardiaPro Portal. The KAI 12L AI can seamlessly integrate with compatible devices. AliveCor offers an enterprise platform with API and SDK solutions for third-party providers to integrate and manage patient ECG data.
AHA/ACC Guideline Alignment
The Kardia 12L ECG accuracy conforms to IEC 60601-2-25:2011 standards for the basic safety and essential performance of electrocardiographs. A study showed that the Kardia 12L ECG System performs comparably to a standard hospital-grade ECG for detecting common morphological cardiac abnormalities, including heart attack.
Real-Time Alert Capability
The KardiaStation app guides the ECG recording process and automatically generates a complete 12-lead tracing. The AI provides FDA-cleared determinations to support clinical decision-making at the point of care. While not explicitly stated as 'real-time alerts' in the traditional sense, the rapid analysis and report generation support faster clinical action.
Physician Tip

Kardia 12L offers a portable and simplified approach to acquiring 12-lead ECGs, making it suitable for various care settings beyond traditional cardiology offices, such as primary care, urgent care, and home health. The dual analysis modes (Asymptomatic and Symptomatic) allow for tailored interpretation based on patient presentation. The reduced leadset and single-cable design simplify acquisition and reduce patient discomfort, potentially increasing patient compliance and workflow efficiency. However, remember that synthesized leads are for informational purposes only and not for primary diagnostic decision-making. Always integrate the AI-powered analysis with clinical history, symptoms, and other diagnostic tests. The device requires activation with a valid National Provider Identifier (NPI) number and the automated analysis should be reviewed by a qualified healthcare professional.

KAI 12L is seamlessly integrated into the Kardia 12L system and the KardiaStation app. AliveCor provides an enterprise platform with API and SDK solutions, enabling third-party providers to integrate ECG monitoring capabilities and patient ECG data into their own systems. This includes features for EHR integration, importing patient ECGs in PDF or raw time series formats, and managing patient data in the AliveCor Cloud. Webhook notifications can alert integrated systems when new ECGs are available. The KardiaStation app is compatible with various iOS and Android devices.

Details

Category Cardiology AI, Lab & Diagnostics, Wearables & Remote Monitoring (RPM)
Pricing $2295
DeploymentMobile device application with hardware
Compliance
BAA Available Yes AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Cardiology, Emergency Medicine, Internal Medicine

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Kardia 12L and KAI 12L

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for Kardia 12L and KAI 12L.

View all on YouTube

Frequently Asked Questions

Kardia 12L refers to AliveCor's 12-lead ECG acquisition device, while KAI 12L (Kardia AI 12L) represents the artificial intelligence algorithms applied to the 12-lead ECG data. Kardia 12L integrates by providing a portable, clinical-grade 12-lead ECG, and KAI 12L algorithms then analyze this data to provide AI-driven insights, which can be incorporated into existing EMR systems for physician review and decision-making.
KAI 12L offers AI-driven insights such as detection of certain arrhythmias, myocardial infarction, and other cardiac conditions. While specific diagnostic accuracy varies by algorithm and condition, studies have shown KAI 12L to have high sensitivity and specificity for certain detections, often augmenting or flagging potential issues for physician review rather than replacing traditional interpretation.
KAI 12L, as a medical AI device, requires appropriate regulatory clearances, such as FDA clearance in the United States, for its intended use. Physicians must ensure that the device and its associated AI algorithms are used in compliance with these regulations, and that all patient data handled by the system adheres to HIPAA and other relevant data privacy laws.
Like all AI, KAI 12L's algorithms may have limitations, such as reduced accuracy in certain patient populations, with specific ECG morphologies, or in the presence of significant artifact. Physicians should be aware of these potential biases and limitations, using the AI insights as a tool to support their clinical judgment rather than as a definitive diagnosis.
Alternatives to Kardia 12L and KAI 12L include other portable 12-lead ECG devices and various AI-powered ECG analysis platforms from different manufacturers. These alternatives may offer varying features, such as different AI algorithms for specific conditions, integration capabilities, and levels of portability, requiring physicians to evaluate them based on their specific clinical needs and preferences.
The pricing model for Kardia 12L typically involves an upfront cost for the device itself, while KAI 12L's AI analysis may be offered through a subscription service or per-use fee. Physicians should investigate potential reimbursement pathways for both the ECG acquisition and the AI-driven interpretation, as these can vary by payer and region.
KAI 12L is designed with robust data security measures, including encryption for data transmission and secure storage protocols, to protect patient privacy. It adheres to industry standards and regulatory requirements like HIPAA to ensure that sensitive ECG data is handled confidentially and securely throughout its lifecycle.

Related Tools

Stethophone Pro
Sparrow Acoustics
Cardiology AI
Stethophone Pro transforms smartphones into advanced cardiac screening tools, enabling clinicians to capture, interpret, and visualize heart sounds for early detection of cardiovascular diseases.
ACUSON Sequoia Diagnostic Ultrasound System, ACUSON Sequoia Select Diagnostic Ultrasound System, ACUSON Origin Diagnostic Ultrasound System, ACUSON Origin ICE Diagnostic Ultrasound System
Siemens Medical Solutions, USA
Cardiology AI
Siemens Healthineers offers advanced AI-powered ultrasound systems, including the ACUSON Origin for comprehensive cardiovascular care and the ACUSON Sequoia for high-performance general imaging with BioAcoustic™ technology.
syngo.via MI Workflows, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, syngo MBF is an intelligent, integrated imaging software that helps address the challenges of interpreting, managing, and sharing complex data from molecular imaging scanners, providing automated workflows and advanced visualization for various clinical applications.
syngo.via MI WorkFlows, Scenium, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, Scenium, and syngo MBF are medical diagnostic post-processing applications for viewing, manipulation, quantification, analysis, and comparison of PET or nuclear-medicine functional data with CT or MR anatomical data across timepoints, supporting disease management and radiotherapy treatment planning by trained healthcare professionals.
ACUSON Sequoia Diagnostic Ultrasound System, ACUSON Sequoia Select Diagnostic Ultrasound System, ACUSON Origin Diagnostic Ultrasound System
Siemens Medical Solutions USA
Cardiology AI
Siemens Healthineers offers the ACUSON Sequoia, ACUSON Sequoia Select, and ACUSON Origin ultrasound systems, providing advanced imaging for various medical needs. The Sequoia line focuses on high-resolution imaging with deep penetration and reduced variability, while the AI-powered ACUSON Origin specializes in comprehensive cardiovascular diagnostics and interventions.
R30 Diagnostic Ultrasound System
Samsung Medison Co.
Cardiology AI
The Samsung Medison R30 Diagnostic Ultrasound System is a general-purpose, mobile, software-controlled diagnostic ultrasound system that offers a wide range of imaging capabilities and analysis tools for various clinical applications.

See all Cardiology AI tools →

More from AliveCor

AliveCor QT Service
AliveCor
Cardiology AI
A cloud-based Software as a Medical Device (SaMD) that provides instant, accurate QT and QTc interval measurements from AliveCor 6-Lead ECGs, enabling healthcare professionals to assess cardiac safety and inform medication prescribing decisions.
Corvair
AliveCor
Cardiology AI
Corvair Monza
AliveCor
Cardiology AI
AliveCor is a medical device and AI company that develops ECG hardware and software compatible with consumer mobile devices for remote heart rhythm monitoring and arrhythmia detection. Their products, such as the KardiaMobile, KardiaMobile 6L, and KardiaMobile Card, provide medical-grade ECG readings and utilize AI for analysis. AliveCor aims to deliver intelligent, highly-personalized heart data to clinicians and patients anytime, anywhere, transforming cardiology.
Impala
AliveCor
Cardiology AI
AliveCor specializes in cardiac monitoring solutions.

View company profile →

Suggest an Edit → | Report an issue | Last Verified: 2026-07-26 | First Added: 2026-07-26

Investors who backed Kardia 12L and KAI 12L

Funded through the company that built this tool.

AI Tool Finder
AI-powered search. Results may not be comprehensive.